SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9.
Published August 10, 2022 · Recall initiated: July 21, 2022
Summary
FDA records drug Class I recall D-1350-2022, published August 10, 2022 and initiated July 21, 2022. Recalling firm: Ultra Supplement LLC; Status: Terminated; Reported quantity: 750 cartons; Lot: Lot DAP272109, Exp: 4/1/2026. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Ultra Supplement LLC
- Distributor
- Product was distributed nationwide in the USA via Amazon Marketplace on www.amazon.com.
- Lot
- Lot DAP272109, Exp: 4/1/2026
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by:August 10, 2022
- FDAAmaranth Grain Organic, brand Natural Grocers, packaged in plastic bag, net wt. 1 LB (454g) UPC 0 00080 12550August 10, 2022
- FDATacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDCAugust 10, 2022
- FDADouble Fudge Blend (04-3118-35) 35lbs. (15.88 KG) packaged in a blue plastic bag (ZZ500) inside a printedAugust 10, 2022
- FDAMatzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, ManufacturedAugust 10, 2022
- FDAKingdom Honey Royal Honey VIP The Ultimate Power Source; 12 sachets-20g; UPC 555755 800036August 10, 2022
Questions about this recall
Was SUSTANGO (Pendenadril Tytrate Blend) Capsules, 400 mg, 10-count blisters per carton, Formulated by: Male FX Labs, Bangor, ME, ASIN X0024468I9. recalled?
Yes. FDA published recall D-1350-2022 on August 10, 2022. Reported hazard: Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release